Join
Live feed
·
INSIDERFilingvia Quantisnow
Concert Pharmaceuticals Inc. logo

SEC Form 4: Stuart Nancy sold $18,631 worth of shares (6,049 units at $3.08) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 284,737 units (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.
CNCE· Concert Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNCE (Concert Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Stuart Nancy sold $18,631 worth of shares (6,049 units at $3.08) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 284,737 units (tax withholding) | Quantisnow